Skip to main content

FDA Delays Decision Over Juul's Vaping Products

FDA Delays Decision Over Juul's Vaping Products

FDA Delays Decision Over Juul's Vaping Products

Introduction

The officials of the Food & Drug Administration (FDA) of the United States delayed the decision of Juul vaping products that would decide the fate of the product in the U.S. market.

FDA banned thousands of electronic cigarettes and related products to prevent underage smoking, but the agency did not rule on Juul, which is the most popular brand among adults and teens. The agency has been repeatedly pressurized by parents, politicians and anti-tobacco advocates to ban the Juul vaping products, but the officials stated they need sufficient time and evidence to proceed.

Companies manufacturing e-cigarettes need to provide precise data about the benefits of the products to public health how they will help to reduce or quit smoking among heavy smokers and prevent smoking addiction among the underage. The companies might be able to survive in the market if they manage to provide such data.

Attorneys for the plaintiffs and families of the affected people are outraged because of the delay in the decision. They even showed concern about the growing addiction problem among teens.

E-cigarettes were introduced in the U.S. market a decade ago to provide a less harmful alternative to smokers. But as per the industry experts, the products did not serve the purpose and fueled nicotine addiction among the teens and adults who smoke.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!